Ceva Animal Health has published Causes of scour in growing pigs: an overview, a technical review on pig scour.
The company says its aim is to provides vets with an easy-reference guide to the main causes and clinical signs of this common and potentially fatal condition.
At best, scour in growing pigs can cause significant weight loss and damage to the intestinal mucosa. At worst it will result in high mortality. Causes of scour in growing pigs: an overview summarises the causative agents of scour throughout the stages of growth, from sucking piglets through to finisher pigs.
Ceva adds that although it is difficult to be too prescriptive about assigning clinical signs to specific diseases because of variable immunity and the occurrence of mixed infections, the review provides useful guidelines to aid accurate diagnosis. Preventative management strategies are also discussed where applicable.
For further product information contact your local Ceva representative or Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
The new sections will sit alongside the Emergency and Critical Care (ECC) pages within the Practical and Clinical Skills section of the bank.
Dental subject areas include diagnosis, radiography and surgery. The new exotic subject areas include an overview, birds, small mammals and reptiles. Surgery subject areas include anaesthesia, peri-operative planning, abdominal surgery, ECC/trauma and post-surgical care.
New grad Ellie Morris MRCVS said: "There are some really good videos on emergency surgeries such as the A-Z of GDV, so when we’ve had quieter days I’ve had chance to look at some of these particularly excellent resources and I feel much more prepared for that situation.
"After watching the Anaesthesia of the Caesarean Section webinar, I discussed what I’d learned with my colleagues and how it compared to their approach. I’ve not done a caesarean yet, but I feel a lot more prepared for when the time does come."
BSAVA President Phil Lhermette said: "This fantastic resource is free to all our members with some sections open to non-members - especially employers, and is growing all the time providing great support for the whole profession at every stage of their career.
"The content is reviewed by committee who are currently helping to expand the Mentor & Employer pages, for practices supporting new graduates, which will be added to the site next."
For more information visit: www.bsava.com/pdp
Millpledge has launched Dermafuse Tissue Adhesive, an n-butyl cyanoacrylate medical adhesive used to bond tissue together following veterinary procedures.
Dermafuse contains a blue dye to help users see where product has been applied.
On contact with body tissue, Dermafuse changes from liquid to solid state by polymerizing within seconds to seal the wound.
Millpledge says the adhesive stops minor bleeding and binds wound edges, which may eliminate the need for sutures or bandages. In some instances it also acts as a barrier to keep foreign matter from entering the wound. The tissue adhesive is sloughed as healing occurs.
Each 3g bottle contains approximately 175 drops. Four sterile applicator tips are provided with each pack.
The RCVS is now accepting disclosures from veterinary surgeons about any criminal cautions, convictions or adverse findings they may have against them, as part of a voluntary period before the requirement to disclose commences in 2014.
The requirement that veterinary surgeons notify the College about criminal cautions, convictions or adverse findings on registration, and on an annual basis as part of their registration renewal each March, was introduced as part of the Code of Professional Conduct in 2012 (section 5.3, see Notes to Editors). However, the College has allowed a bedding-in period for the Code before enforcing the requirement.
From 2014, new registrants will have to disclose any criminal cautions, convictions or adverse findings that may affect registration (for example, those from university fitness to practise procedures).
Veterinary surgeons already on the Register (including overseas and non-practising categories, as well as UK-practising) will only be required to disclose criminal cautions, convictions or adverse findings that have occurred since April 2006. Fixed-penalty motoring offences are excluded.
The veterinary profession has fallen under the Notifiable Occupations Scheme since April 2006, which means that serious convictions are already passed to the College from the police.
If a veterinary surgeon declares a criminal conviction, this will be initially considered by the Registrar, and, if necessary, referred to the Preliminary Investigation Committee. In some cases, the matter will be referred on to the Disciplinary Committee to decide if the nature of the caution or conviction affects the veterinary surgeon's fitness to practise - in which case the usual sanctions of removal or suspension from the Register could apply.
Eleanor Ferguson, Head of Professional Conduct said: "We hope, through this new requirement, to increase the public's confidence in the veterinary profession, and to safeguard animal health and welfare. The move brings the veterinary profession into line with many others - including registered veterinary nurses, who have made such a disclosure since their Register was introduced, in 2007."
The RCVS has launched a dedicated advice line to assist affected veterinary surgeons, on 07818 113 056, open Monday to Friday, 11am-4pm.
Callers will speak to one of three RCVS solicitors who can advise on the process and the possible outcomes of disclosure. Alternatively, veterinary surgeons can contact disclosure@rcvs.org.uk.
Detailed information regarding the requirement, including examples of the kinds of convictions that may be referred to the Preliminary Investigation Committee, and a disclosure form, can be found on www.rcvs.org.uk/convictions.
It's just over a year since microchipping became compulsory for dogs and according to Defra, 95% of dogs are now chipped.
However, the PDSA PAW Report 2016 showed that only 20% of Britain's 11m cats live an indoor-only life, meaning that there are 9 million 'free-range' cats at risk of getting lost if they stray too far from home.
The PDSA report also found 91% of veterinary professionals in the UK believe microchipping should be compulsory for cats.
Bayer says that advice to dog owners this year should focus on the importance of keeping their chip registration details up to date, after a BVA survey found 44% of veterinary surgeons still cannot reunite missing or stray dogs with their owners due to incorrect chip information being stored on the databases.1
Hannah Watts, Product Manager at Bayer said: "Until microchipping becomes compulsory in cats, vets will need to play a crucial role in helping increase the number of UK cats that are microchipped. National Microchipping month provides a great opportunity for vets to raise the subject with owners and to take advantage of the increased awareness and interest in the subject throughout June. With so many dogs now microchipped, ensuring owners are aware of the need to update their details on the microchipping database is an equally important educational message for vets to convey."
Bayer says that during National Microchipping Month, it will be actively driving pet owners into veterinary practices across the country to discuss the benefits of microchipping with their veterinary surgeon. It will also be trying to ensure pet owners understand the importance of keeping the details stored on their pet’s microchip database up to date.
To help drive home the message, Bayer has also developed a range of new marketing and support materials for practices to display throughout June.
To order National Microchipping Month support materials, visit www.vetcentre.bayer.co.uk or speak to your Bayer Territory Manager.
Reference
60 vets took part in the survey. 80% believed they had seen an increase in behavioural problems since lockdown. Over 60% reported an increase in the incidence of obesity and diarrhoea. Nearly 50% had seen an increase in urinary tract disorders and haemorrhagic gastroenteritis.
When asked which conditions had been harder to manage clinically since the start of the pandemic, the top seven conditions were:
Medicine specialist, Dr Stefanie Mitze (pictured right) said: “We conducted the survey to help us understand changes in disease incidence and the clinical challenges faced by our colleagues in first opinion practice over the last year.
"The fact that the incidence of disorders which can have a stress-related component, including behavioural problems, diarrhoea and urinary tract disease, were reported to have increased by a high proportion of respondents indicates that many pets may be experiencing heightened stress during the pandemic.”
Stefanie is now creating a series of free bitesize CPD videos to help manage these more challenging cases. She said: “We recognise the past year has been challenging, especially with complex staffing issues, reduced vet visits and restricted face-to-face communication with clients. For complex, chronic medical conditions, especially those which require frequent follow up, we wanted to support colleagues in providing the best care possible in the current circumstances. We hope these CPD sessions will provide practical tips to help deliver just that.
The CPD sessions are available at: https://www.hamiltonspecialists.vet
Animalcare has announced the UK and Ireland launch of Vitofyllin, a central nervous system stimulant for older dogs suffering from dullness, poor demeanour and unwillingness to exercise.
The launch of Vitofyllin is the result of a collaboration between Animalcare and three European partners.
The company says the project has enhanced its in-house expertise because the active ingredient for the product was unavailable in the market and had to be contract synthesised, a first for a new product development at Animalcare. The regulatory procedure was also the first time a bioequivalence bio-waiver had been successfully applied for and obtained in Europe. This made the development quicker, more cost effective, less risky and importantly avoided the need for animal testing.
Animalcare says that as in previous years, it has set itself a target of launching four new veterinary medicines during the year. This launch is the first of those planned for the new financial year.
Stephen Wildridge, CEO of Animalcare Group, said: "We are very pleased to be able to add our new generic medicine Vitofyllin to our range of licensed veterinary medicines. The launch represents the culmination of the biggest development project undertaken by Animalcare and is the product of successful collaboration with members of our European partnership network."
Eastcott says all staff working in the ECC unit have received specific intensive care training and will be supported by discipline-specific specialists at all times.
The service will be run by three ECC/medicine vets during the day and three ECC vets at night, supported by four day nurses and two night nurses.
David said: “We’ve created a purpose-built intensive care unit with all the latest ICU equipment, including our own laboratory; critical care cribs; temperature, humidity and oxygen-controlled intensive care kennels and an ICU ventilator.
“This means we have the facilities to care for the most severely injured and critical cases.
“We also have a high-quality team of enthusiastic, dedicated ECC vets and nurses to lead the service. Everyone has a background of ECC work and a true passion for it.”
Harriet said: “By having all the specialist disciplines available at the practice, we can offer a more holistic service to emergency patients. For example, if a dog is involved in a road traffic accident, the ICU can stabilise it and give emergency care and pain relief.
“Dentistry can then repair jaw and mouth injuries; orthopaedics can repair any other broken bones and soft tissue can assess and repair any damaged organs. This is all supported by our dedicated anaesthesia service and advanced imaging capabilities.
“The ICU also provides a calm environment for critically ill and injured patients to recover following surgery or other planned treatments from other disciplines.”
For more information, visit www.eastcottreferrals.co.uk.
The specialist-led lectures will start on 5th May and run until October 2021, with a session every couple of weeks, alternating between vets and nurses.
RCVS-recognised specialist in ECC, Tobias Grave, and Racheal Marshall RVN, head of clinical nursing at Vets Now, are among the speakers who will be covering topics such as damage control resuscitation, traumatic brain injury and neurotoxins. You can view the full programme here.
Dan Lewis, ECC specialist at Vets Now, who devised this year’s veterinary CPD programme, said: “Because emergencies don’t only happen out of hours we’re committed to working with general practitioners to deliver the best possible care to pets at the time they need it most. With that in mind, we are also committed to bringing relevant and pioneering CPD and training to veterinary clinicians and vet nurses.
“As emergency and critical care experts, we appreciate the value of flexibility and are always looking to adapt our services. In 2021, with social distancing still expected to be the norm, we’re offering two CPD streams, available live and on-demand.
“We delivered a successful interactive learning experience for virtual delegates through our ECC Congress at the end of last year, so we have a strong foundation from which to build on innovative and expert virtual CPD, and we’ll aim to leave delegates feeling well-informed and assured.
“We will obviously miss seeing everyone in person but gathering together online like this is beneficial as we can reach more vets and vet nurses with valuable CPD. Importantly, the format can fit around busy schedules, with all content available as videos after the events have taken place.”
Dan added: “Delegates from our ECC Congress commented on some added benefits of the virtual format including things like less environmental impact and waste through less travelling, and more flexibility due to being able to look back on the content after the event. Delegates also felt it was easier to ask questions of the speakers without feeling intimidated.”
The event series is priced at £72 for the vet stream (working out at £12 per session) and £60 for the vet nurse stream (£10 per session). You can also attend both for £110 (working out at £9.16 per session).
You can book your place at www.vets-now.com/bitesize.
Global names in gastroenterology will be sharing the latest knowledge to help veterinary surgeons and nurses support the work of the BHS and Nottingham University’s REACT to colic campaign, which is designed to help vets and horse owners work together for colic patients.
On Friday 13th September there'll be a two-hour session chaired by Harry Carslake, a diplomate of the American College of Veterinary internal medicine (ACVIM). The session will involve five experts speaking about aspects of colic, followed by discussion and the opportunity for questions from delegates.
Natasha Jocelyn, Internal Medicine Specialist, Sussex Equine Hospital, will speak about managing the acute colic in the field: what to do when flunixin doesn’t work.
Prof. Dr. Gunther Van Loon European Veterinary Specialist in Equine Internal Medicine, Ghent University, Belgium, will discuss managing acute colic in the equine hospital.
Dr Nathan Slovis member of the American College of Internal Veterinary Medicine, Director of the McGee Medicine Department and a partner at Haygard Equine Medical Institute in Lexington, Ky will explain colic guidelines – can ‘algorithms’ help?
Prof. Dr Lutz Goehring European Veterinary Specialist in Equine Internal Medicine, Ludwig-Maximilians University Munich, will explore the question ‘is there an evidence-based approach to managing enteritis?’
David Rendle European Veterinary Specialist in Equine Internal Medicine, Rainbow Equine Hospital, North Yorkshire, will look at parasitic disease as a cause of colic and methods of management.
All BEVA Congress delegates get a certificate of attendance worth seven hours of CPD.
If you're struggling for time or torn between several lectures you can use the BEVA Congress Encore Room to play back missed lectures at your convenience. BEVA Congress is also providing day crèche for children between the ages of 0-8 years. Find out more here.
Anyone who registers for Congress before 8 May 2019 will receive significantly reduced booking fees, and BEVA members save up to £379 on their Congress passes.
The researchers’ objective was to determine whether dogs with intracranial space occupying lesions (iSOLs) on MRI, or MRI-determined indicators of intracranial hypertension (ICH) had higher sedation scores with a more rapid onset of recumbency after the administration of IV butorphanol than dogs without intracranial disease.
They hypothesised that 0.2 mg kg-1 of butorphanol administered intravenously would result in statistically significantly higher sedation scores and quicker onset of recumbency in dogs with MRI-iSOL and MRI-ICH.
For the observational study: 'The sedative effect of intravenous butorphanol in dogs with intracranial space occupying lesions or indicators of intracranial hypertension', 53 dogs presented for a brain MRI.
Each dog was sedated with 0.2 mg kg-1butorphanol IV, and the quality of sedation and the onset of recumbency were scored before drug administration and every 5 minutes after administration for 15 minutes using a modified sedation scale.
The maximum sedation score was 18, and onset of recumbency was recorded when a dog lay down without the ability to stand.
Dogs with MRI-iSOL had significantly higher median sedation scores than dogs without MRI-iSOL (12 versus 5 respectively) 15 minutes after butorphanol administration (T15, p < 0.01).
A greater number of dogs with MRI-ICH achieved recumbency (n = 9/10; 90%) than those without MRI-ICH (n = 20/43; 46.5%; p = 0.01).
Emma Sansby, Resident in Anaesthesia and Analgesia at Lumbry Park Veterinary Specialists, who led the research, said: “When intracranial disease is suspected, the administration of butorphanol as a premedicant for anaesthesia could be used to predict the presence of MRI-iSOL and MRI-ICH.
"If a dog becomes recumbent or has a sedation score of more than 10 within 15 minutes of butorphanol administration, the animal should be treated with an anaesthesia protocol adapted to the presence of ICH – so as not to increase intracranial pressure.
“These adaptations include but are not limited to; adequate preoxygenation - to prevent hypoxaemia and elevation of the head to no more than 30 degrees; preventing increases in central venous pressure - by avoiding jugular compression and avoiding excessive intraabdominal and intrathoracic pressure; and a smooth anaesthetic induction - ensuring an adequate depth of anaesthesia prior to tracheal intubation to prevent the cough reflex and judicious mechanical ventilation to enable a low-normal end-tidal carbon dioxide.”
Photo: www.depositphotos.com
Vethelpdirect.com, the website founded by VetSurgeon.org member, Susie Samuel MRCVS, has launched a new system called VetReviews which allows your clients publish a review of your service directly from your own website.
To use the system, you (or perhaps more likely your website person) embed a small form on your website, called a widget, as shown on this example: www.baytreevets.co.uk (bottom right hand side).
Clients then click the link in the widget to submit a review of your practice, or to read existing reviews.
To ensure fair play, each review is checked by a person who removes any spammy or malicious reviews, and looks for any signs of fraudulent multiple reviews being submitted by one person.
In the event of a negative review, the practice is given 5 days to respond before the review is published, which means the review isn't displayed without the practice's side of the story.
However, as Susie points out, a single negative review is not necessarily a bad thing; most people are able to put one bad review into context. Indeed, a small number of negative, or less positive reviews tends to make the glowing ones seem more credible.
VetReviews are optimised for inclusion in Google search results, which should also help your search engine visibility.
For more information about VetReviews (which is a free upgrade for existing customers), email: vets@vethelpdirect.com, or telephone 0845 4961 204.
The RCVS Disciplinary Committee has reprimanded and warned as to his future conduct a Hampshire veterinary surgeon found guilty of serious professional misconduct for cumulative failures to provide adequate professional care, and insufficient regard for animal welfare whilst treating a dog that had ingested broken glass.
The sanction was decided following a 12-month postponement of a decision ordered at a hearing on 19 November 2010.
At last week's hearing, the Committee was asked to decide what sanction would be appropriate in the case of Peter Ardle MacMahon for his treatment of a Cocker Spaniel called Wilfred, while working as a locum in Portsmouth. In 2010, the Committee found that Mr MacMahon had not removed the ingested glass from Wilfred's stomach or adequately checked that he had done so; had inadequately prevented abdominal contamination; and, had failed to communicate this contamination problem to Wilfred's usual veterinary surgeon. Considering these charges cumulatively, the Committee found that the treatment Mr MacMahon provided to Wilfred had fallen far short of the standard to be expected in the profession and amounted to serious professional misconduct.
Shortly prior to treating Wilfred, Mr MacMahon had returned to practice after a ten-year absence and, at last year's hearing, agreed to comply with undertakings regarding his professional development. These included performing at least 70 hours of medical and surgical continuing professional development (CPD); providing the Disciplinary Committee Chairman with quarterly CPD reports and two employer reports regarding his competence; observing 24 days of current practice by shadowing another veterinary surgeon; and, providing reports from this veterinary surgeon as to his competence and a case diary.
The Committee considered the factual findings from the November 2010 hearing and the concerns then expressed about Mr MacMahon's conduct and capabilities as a veterinary surgeon, as well as his compliance with the agreed undertakings. As advised by the Legal Assessor, the Committee's considerations of sanction began at the lowest level that would ensure that the welfare of animals was properly protected; that proper standards would be maintained among practitioners in the profession; and, that would be in the interests of the public.
Speaking on behalf of the Disciplinary Committee, Chairman Professor Peter Lees said: "The Committee is satisfied that the respondent had complied fully with the spirit of the requirements of the undertakings he had entered into on 18 November 2010. Indeed, the view is that the respondent has done well to achieve the level of compliance that he has, given that he had suffered a period of significant ill-health during the period since he entered into those undertakings.
"The ultimate decision is that the respondent's conduct [...] warrants the imposition of at least a reprimand," he continued. "However, it is also the Committee's firm view that the respondent must be warned about his future conduct so that he will know the Committee considers he needs to maintain the level of continuous professional development that he has achieved [over the last] 12 months, and to have constantly in mind the paramount obligation of all veterinary surgeons to ensure the welfare of animals under their care.
"Such a warning as to future conduct should, and the Committee believes that it will, serve as a constant reminder to the respondent that he must undertake only those procedures, and only proffer professional advice, in the areas where he has the requisite up-to-date skills, knowledge and experience."
The Committee reprimanded Mr MacMahon and warned him as to his future conduct.
Ceva Animal Health has launched Cystease Advanced, a new urinary tract support supplement for cats.
The new product, which contains N-acetyl glucosamine, L-tryptophan and Hyaluronic Acid, is described as an elaboration on the original product, Cystease S.
Ceva says Cystease Advanced has been designed to help support the bladder lining while also reducing stress-related behaviour in cats.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "It is well documented that stress can adversely affect the integrity of the bladder lining. There are many factors that cause stress in cats, for example inter-cat conflict, moving house, new arrivals to the home environment and car travel, to name just a few.
"Our new product has been developed to address both conditions; it contains N-acetyl glucosamine and Hyaluronic Acid which are key components of the GAG lining, whereas L-tryptophan has been proven to reduce stress-related behaviour in cats."
Cystease Advanced is taken orally and is available in pots of 30 and 300 tablets.
Ceva recommends that Cystease Advanced is used with Feliway, the company's appeasing pheromone for cats.
For further details please contact the customer support team on 01494 781510.
RVC researchers say that the VetCompass study is the largest ever carried out into dental disease in cats using veterinary clinical records.
The study investigated a sample of 18,249 cats randomly selected from a study population of 1,255,130 cats in the UK in 2019.
Periodontal disease was recorded in 15.2% of the sample making it the most common disorder.
The cat breeds with the highest annual levels of this diagnosis were Siamese (18.7%), Maine Coon (16.7%) and British Short Hair (15.5%) as well as crossbreeds (15.4%).
The average bodyweight of cats with periodontal disease (5.7kg) was higher than for cats without periodontal disease (5.5kg).
The risk of periodontal disease rose steeply as cats got older, with cats aged 9 to 12 years being 6.7 times more likely to have periodontal disease compared with cats aged under 3 years.
Cats with periodontal disease were much more likely to have a range of other health conditions compared to cats without periodontal disease (x 1.8 risk).
These conditions included cardiac dysrhythmia (x 2.3 risk), ear discharge (x 2.3 risk) and hairball/furball (x 2.3 risk).
The researchers say that these findings suggest that periodontal disease should be acknowledged as a leading health and welfare issue in cats, and highlight the need for greater dental care in cats as they age.
The study was supported by an award from the Kennel Club Charitable Trust and Agria Pet Insurance.
This third biennial offering from GB’s Cattle Health and Welfare Group also contains a summary of progress on endemic disease control with advances in eradicating Bovine Viral Diarrhoea (BVD) in each country highlighted.
The Chief Veterinary Officers of UK, Scotland and Wales have welcomed the publication of the report saying that as the possible impacts of the referendum on leaving the EU are considered, the importance of a GB focus on disease control is as important as ever.
In their joint forward, Nigel Gibbens, Sheila Voas and Christianne Glossop said: "The healthier our animals, the more attractive our products. The better our animal welfare, the greater the confidence of consumers in our production systems.
"With the UK Government placing AMR at the top of its risk register alongside terrorism and pandemic ’flu, it is heartening to see that CHAWG, in common with other livestock sectors, has grasped the nettle in looking first at how the cattle sector can better capture data on use of antimicrobials."
They go on to say that addressing AMR helps address other imperatives as an emphasis on sound animal husbandry and healthy animals kept to high welfare standards will help minimise routine reliance on antimicrobials: "Success in controlling endemic disease is one area of considerable importance, and here we can highlight CHAWG’s pivotal role in the development and promotion of national disease control programmes. These include the launch of the BVDFree scheme in England earlier this year, ongoing progress with BVD eradication in Scotland, the development of a Wales BVD scheme, and the Action Johne’s initiative."
In the report’s conclusion, RSPCA’s head of farm animals Marc Cooper points out that it is clear many positive initiatives are being pursued within the industry. He said: "Notable amongst these are those associated with dairy cow genetics, eliminating BVD, the national dairy cow welfare strategy and the development of a data hub for the collation of information relating to antimicrobial use.
"Indeed, some of these are starting to realise improvements in key areas, for example, dairy cow longevity is beginning to increase, and cow fertility figures and somatic cell counts appear to be moving in the right direction.
"However, there are still ongoing concerns relating to some important health and welfare issues. For example, despite the evidence suggesting the annual prevalence levels of cattle lameness are beginning to fall, there still appears to be no centralised database for recording it."
Chairman of CHAWG Tim Brigstocke says the contributed comments are encouraging and provide positive direction for future CHAWG activities. He also reassures that while this report sees a number of advances in highly topical areas, ‘core’ activities are not being ignored. He said: "Effective farm health planning remains the bedrock of good practice. And while we tend to focus on areas which need improvement, it’s worth mentioning that a delegation from the Food & Veterinary Office (FVO) of the European Commission recently visited and were impressed by the coordinated approach taken in this country."
The report can be downloaded from www.chawg.org.uk.
The toolkit includes a 15-minute CPD webinar: ‘How to best use ProZinc to successfully manage diabetes in cats and dogs’, hosted by Dr Jamie Adams BVSc PhD MRCVS, Senior Brand Technical Advisor at Boehringer Ingelheim.
Vets who watch the webinar can enter a competition for a coffee machine for their veterinary practice by answering three questions at the end.
The toolkit also has a diabetes management reference guide covering how to make a confident diagnosis and start treatment with ProZinc, how best to monitor and reassess the patient and how to adjust the dose for optimal control.
There are also glucose curve charts, pet owner guides, home care journals and a link to the ProZinc pet owner website, www.prozinc.co.uk, which contains information to help owners feel confident in managing their pet’s diabetes.
The webinar and toolkit are available from: www.boehringer-academy.co.uk.
The tracker, which Elanco produces with NADIS (National Animal Disease Information Service), highlights areas hit with blowfly strike in real-time, to provide a warning for farmers, veterinary surgeons and industry professionals.
The first reported incidents were in Hampshire, before spreading across Devon, West Sussex, and Buckinghamshire. Elanco says particularly severe cases include a flock in Dorset, in which 50% of a lamb group have been hit by blowfly strike. Latest reports are in northern England and some initial cases in Scotland.
The company says its blowfly risk forecast suggests that weather conditions from southern England and Wales to the Midlands mean that flies are now active, and females are laying eggs that could result in serious welfare and productivity issues.
Richard Wall, Professor of Zoology at Bristol University, said: "The timing and severity of blowfly strike is strongly influenced by the weather. This is a reminder to farmers that now is the time to act for early prevention. Delaying treatment not only costs the farm but risks the welfare and productivity of the flock."
Fiona Hutchings, Technical Vet at Elanco, said: "The costs of inaction when it comes to blowfly strike far outweigh the costs of protection. With 99% of farmers having suffered financial losses as a result of blowfly strike¹, the potential impact on your flock simply isn’t worth the risk. Farms need to take control — and take control early — by using a preventative IGR product with full fleece protection2."
Fiona added: "By the time symptoms show themselves, it’s often too late. It’s easy to overlook even one struck sheep, and blowfly strike can cause huge damage in very little time. In addition, using protection early reduces risk later in the season by ensuring a much lower fly count as the season progresses."
The web based app, which has been launched in association with the BSAVA, provides a library of medical summaries drawn from global guidelines and peer-reviewed journals.
Vet2Vet co-founder Dr Zoe Coker said “There is rarely time during the working day to read all the necessary journals, articles and up-to-date texts. VETbytes collates all the evidence on a specific medical condition and consolidates it into a short synopsis called a Keep it Simple Summary (KISS)."
BSAVA President Professor Ian Ramsey said: “BSAVA is excited and proud to be involved in the VETbytes project, which should provide significant benefits and support for our members. Every busy small animal clinician should try out VETbytes as it is a real paradigm shift in mobile resources for vets.”
The VETbytes app currently covers more than 100 topics developed in consultation with more than 25 veterinary experts. Further benefits include drug (and CRI) calculators, a quick reference section and links to hundreds of source abstracts. The content encourages reflective learning and can be used towards CPD hours.
VETBytes is available on subscription with reduced rates for BSAVA members and free access for veterinary students.
To start a free trial or subscribe to the VETbytes app, visit www.vetbytes.co.uk.
The company has launched a ‘Vet Show CPD hub’ (www.myelanco.co.uk/brand/lvshub) which, as the name suggests, hosts a variety of CPD presentations accompanied by competitions, including one in which you can win £250 Amazon vouchers.
The CPD hub also has information about the company's range of products, including Credelio, Neptra, Galliprant and Advocate.
From the 10th November, Elanco will also host a series of webinars in partnership with the London Vet Show (https://london.vetshow.com/elanco):
As a thank you, the first people to sign up to the webinars will also get an ‘Elanco Vet Show CPD at home’ box, with goodies to enjoy while tuning into the virtual event.
Tina Hunt, managing director of Elanco UK/Ireland, said: "2020 has been a year of incredible change, which has included our global acquisition of Bayer Animal Health. While we remain physically separated, it is important to us that we continue to engage with our veterinary friends and customers to maintain the sense of community that networking events can be so vital in nurturing.
"We also wanted to take this opportunity to recognise the commitment of veterinary professionals across the UK and thank you for your ongoing support and dedication at the forefront of animal care. Our entire team look forward to you joining us for three exciting webinars and to hosting you on our hub."
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."
As part of the scheme, Linnaeus offers one-to-one mentoring, professional and clinical skills development in primary care practices across the UK as part of the scheme.
The group, which now has more than 3,000 employees, delivers all clinical training in-house through its network of specialists, referral clinicians, certificate holders and primary care clinicians.
The 2021 programme applications will remain open until the end of May, unless all positions are filled sooner.
Chloe Roberts, clinical and educational development manager at Linnaeus, said: “This will be the fourth cohort to join our GDP and we’re looking forward to building on the successes we have enjoyed over the last three years.
“This has been a challenging year for obvious reasons, so it has been extremely heartening to see our new vets rise to that challenge and continue their professional journeys with our support.
“We’re excited to hear from the next intake of new vets and look forward to supporting them in their transition to clinical practice and recognise the additional challenges they faced joining the profession in the midst of a global pandemic.”
For more information, visit graduates.linnaeusgroup.co.uk or www.instagram.com/linnaeusgdp.
Researchers at the University of Saskatchewan's Western College of Veterinary Medicine (WCVM) are carrying out a survey of equine practitioners to discover, amongst other things, just how common Cushing's disease is internationally.
The 16-question survey was launched this month and will be available for a further six months at www.wcvm.com/veterinarians/cushings_survey.php
Dr. James Carmalt, an equine surgeon and associate professor in the WCVM's Department of Large Animal Clinical Sciences said: "Our objective is to determine the true prevalence of Cushing's disease worldwide, because until now, previous surveys were only based in the U.S."
Dr. Carmalt is also a PhD student in equine neurophysiology through the western Canadian veterinary college's Department of Veterinary Pathology. He and his graduate supervisor, veterinary pathologist Dr. Andrew Allen, are beginning to explore a new treatment methodology for equine Cushing's disease.
Researchers will use practitioners' responses to the brief survey to determine the incidence of the disease and the most common treatment protocols being used by practitioners in countries around the world. They also want to evaluate the need for developing new treatment methodologies. Dr Carmalt said: "Right now, the only available treatment for Cushing's disease requires daily dosing of medications for the rest of the horse's life. It's onerous, time consuming and a huge management challenge.
"If the responses from this survey reflect our impression that practitioners need a new option to offer their clients, our ultimate goal is to develop a one-time treatment for the disease so daily medications for Cushing's disease become unnecessary."
For more information about the Cushing's disease survey for equine practitioners, please contact Dr. James Carmalt (james.carmalt@usask.ca). As part of the survey, practitioners can also provide their email addresses if they wish to receive a copy of the survey results.
The book contains 40 chapters of articles about clinical techniques, diagnostic pathways and management approaches published in Companion between 2016 and 2020.
Editor of Companion, Samantha Taylor said: “At Companion we strive to produce well-illustrated, practical articles to help vets and VNs in practice face the day-to-day challenges of a varied caseload. We hope this collection meets our aims by covering a variety of clinical problems from hypercalcaemia in cats to managing the snuffly rabbit, from Leishmaniasis to lymphoma and many more.
Ian Ramsey (BSAVA Senior Vice President) said: “This collection represents a unique body of well-illustrated work prepared by experts from all around the UK and beyond. I would like to thank them all on behalf of BSAVA members and readers of this book for taking the time and care to develop these resources for their colleagues around the world.”
Samantha added: “Whether kept on the shelf for when needed or thumbed through over a cup of tea, we hope that within the pages of this new volume you find a useful tip or technique that helps.”
The How to…collected articles from BSAVA Companion (2016–2020), 3rd edition has been published as a BSAVA member loyalty reward gift for those eligible veterinary members who renew their membership this year.
The book is also available to buy from the BSAVA website www.bsava.com/shop priced at £20.
Mr Beveridge had been removed from the Register following a disciplinary hearing in May 2013 in which he was found guilty of disgraceful conduct in a professional respect with the Committee finding that he had treated clients badly, kept inadequate clinical records, was dishonest in his dealings with the College and that animals in his care were placed at risk. He subsequently appealed to the Privy Council but this was later withdrawn, resulting in him being formally removed from the Register in March 2014.
He first applied to be restored to the Register in 2015 but his application was refused by the Disciplinary Committee at a hearing in November 2015. At the time the Committee found him unfit for restoration to the Register because, following his removal, his veterinary medicines account had been used on an unauthorised basis to order prescription-only veterinary medicines, which reflected a "cavalier attitude to practice". Furthermore, the Committee found that he had not fully accepted the Committee’s original findings, had made inadequate effort in regards to engaging in continuing professional development (CPD) and also considered the seriousness of the original findings.
At the opening of his second hearing Mr Beveridge, who represented himself, sought to address the concerns that the Disciplinary Committee had outlined upon refusing his first application for restoration. Regarding his acceptance of the original findings, the Committee heard that he now apologised "unreservedly for his failings that led to erasure of his name from the Register" and the Committee considered that he had demonstrated a significant change in attitude from the previous restoration hearing where he had not fully accepted the reasons for being removed.
In considering issues of public protection the Committee also accepted that Mr Beveridge, until his original Disciplinary Committee hearing, had an unblemished professional record and had run a successful small animal practice for over 30 years. It considered numerous client testimonials as well as a petition signed by 600 clients from 2013.
The Committee also considered that there was no risk to the future welfare of animals in the event of Mr Beveridge being restored to the Register, noting the testimonials and references to satisfactory care and treatment given by Mr Beveridge to his patients.
Regarding CPD, Mr Beveridge produced evidence before the Committee that he had attended courses run by the North American Veterinary Community (NAVC) and the British Small Animal Veterinary Association (BSAVA). The Committee accepted that he had made "considerable progress" in terms of CPD.
In concluding the hearing Judith Way, chairing the Committee and speaking on its behalf, said: "It is the judgement of the Committee that the conduct which resulted in the applicant’s name being removed from the Register is unlikely to be repeated. The applicant has satisfied the Committee that he is fit to be restored to the Register."